It's time for the Lightning Round. Cramer makes the call on viewer favorites.» Read More
This sector offers long-term growth, even in a slowdown. Even oil can’t promise that.
The market traded sideways on Tuesday with Dow finishing slightly lower and the S&P 500 closing a little higher.
Russia's RTS Index was the first global index to hit the correction stage (down 23 percent since hitting its recent high on June 2nd), but now the MSCI Emerging Markets Index (EEM in its ETF form) is also down double-digits since hitting its recent high on June 1st.
This takes the prize for the most dangerously optimistic acronym for a clinical trial. But MADIT (pronounced "made it") made it. Some folks with a lot of chutzpah at Guidant, now owned by Boston Scientific, apparently came up with the name for their big studies on implantable cardio defibrillators.
Cramer makes the call on viewers' favorite stocks.
The president’s budget changes sent stocks tumbling, some undeservedly so.
Amid the gloom, Birinyi Associates' Cleve Rueckert found what he sees as a bright spot in the stock market. In a note, he says growth is the place to be, based on performance of the S&P's Pure Growth Index versus the S&P Pure Value Index. Here's his list of 15 stocks in the S&P 500 that fit three key growth criteria.
This company has heart, Cramer says. Find out how BSX fought its way off the operating table.
It’s easy to like a company that, even in this environment, is focused on taking share.
Intuitive Surgical, a California company that makes endoscopic instruments, is running higher along with heavy options activity amid takeover rumors.
Following are the day’s biggest winners and losers. Find out why shares of Texas Instruments and Hershey popped while Valero and McGraw-Hill dropped.
Boston Scientific is fighting to break out of its recent trading range as a large block of puts changes hands. BSX opened today by more than 2 percent from its close of $7.60 yesterday... The put activity coincides with a company setback in its protracted court battle with Johnson & Johnson.
To give investors an edge, CNBC asked the experts for their best trades now.
Following are the day’s biggest winners and losers. Find out why shares of Charles Schwab and UPS popped while Chicago Bridge & Iron and Gannett dropped.
Oil's move could be a key trend in Wednesday's markets, as traders watch more Fed testimony, a bunch of earnings reports and another helping of inflation data.
The Lightning Round is extended in this new CNBC.com exclusive feature.
Spring is finally in the air, and CNBC asked the experts how investors can best position their portfolios before the long weekend ahead.
Stocks are tumbling. Bonds yields are falling faster than Hillary Clinton's poll numbers. And fears are growing that the commodities bubble could burst. What to do?
The economy's worsening. So's inflation. And the stock market is tanking. What to do? CNBC asked market experts for their best investment advice. Here are some of their picks.
What stocks does a five-star fund manager think about on a less-than-stellar day? It's a good question for Tom Ognar, manager of Wells Fargo's Advantage Growth Fund. He offered CNBC his investment "game plan."